GABRG2 rs9888739: Understanding GABAergic Signaling Variants
The rs9888739 variant is a common genetic marker located within the GABRG2 gene. It is studied for its potential role in modulating GABAergic signaling pathways, which are essential for brain function and have been linked to epilepsy susceptibility.
What each genotype means
Typical GABAergic signaling
This genotype represents the most common form of the GABRG2 gene in the general population. Research indicates that individuals with this profile do not carry the specific variant associated with increased epilepsy susceptibility in this context. Please note that genetic risk is complex and influenced by many factors beyond a single variant.
This is the most common genotype observed across most global populations.
Potential altered GABAergic signaling
Carrying one copy of this variant may be associated with variations in GABAergic signaling, which plays a role in brain excitability. While some studies link GABRG2 variants to an increased susceptibility to febrile seizures or certain forms of epilepsy, the clinical significance of this specific variant remains under investigation. You should discuss any personal or family history of seizures with your healthcare provider.
This genotype is found at varying frequencies depending on ancestral background, appearing in a subset of the population.
Increased epilepsy susceptibility
This genotype is associated with variations in GABAergic signaling that may influence susceptibility to certain seizure disorders. Research suggests that variants in the GABRG2 gene can impact the function of GABA-A receptors, which are critical for regulating brain activity. If you have concerns regarding neurological health or seizure history, please consult with a neurologist or genetic counselor.
This genotype is less common than the major allele homozygote and its frequency varies significantly across different global populations.
What is rs9888739 and Where is it Located?
The rs9888739 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. This gene is located on the long arm of chromosome 5 (5q34). In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. Because rs9888739 is located within a gene that encodes a critical component of the brain's inhibitory system, researchers monitor it to understand how subtle DNA differences might influence neurological health. It is important to note that being a common variant, rs9888739 is found in a large portion of the general population, and its presence alone does not indicate a medical condition. It is simply one of many variations that contribute to the natural genetic diversity observed across human populations worldwide.
The Role of the GABRG2 Gene
The GABRG2 gene provides instructions for creating the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are ligand-gated ion channels that respond to gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the mammalian brain. By allowing chloride ions to flow into neurons, these receptors reduce neuronal excitability, effectively acting as a 'brake' on brain activity. The gamma-2 subunit is particularly important because it is required for the proper trafficking and clustering of these receptors at the synapse. When GABRG2 function is altered, the balance between excitation and inhibition in the brain can be disrupted. While rare, severe mutations in this gene are well-documented causes of various epilepsy syndromes. Common variants like rs9888739 are investigated to see if they contribute more subtly to the overall regulation of this critical inhibitory pathway.
Research and Evidence Strength
The evidence linking rs9888739 to clinical outcomes is considered moderate. While the GABRG2 gene itself is strongly established as a major player in epilepsy genetics, the specific impact of the rs9888739 variant is less definitive. Scientific studies often examine this SNP in the context of polygenic risk scores or as part of broader investigations into GABAergic signaling. Current research suggests that while variations in this gene can influence seizure thresholds, the effect of any single common SNP is usually small and highly dependent on an individual's entire genetic background and environmental factors. It is crucial to distinguish between rare, highly penetrant mutations that cause severe disease and common variants that may only slightly modulate risk. Consequently, this variant is not used as a standalone diagnostic tool for epilepsy or any other neurological disorder.
What You Can and Cannot Do With This Information
Genetic information regarding common variants like rs9888739 is primarily educational. You cannot use this information to diagnose yourself or others with epilepsy or any other health condition. Because epilepsy is a complex, multifactorial disorder, a single SNP cannot predict your health outcomes. If you have concerns about seizures, neurological symptoms, or your family history, the most important step is to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your personal medical history and clinical presentation. Furthermore, if you are currently taking medication for epilepsy or other neurological conditions, never change your dosage or treatment plan based on genetic test results without first speaking to your clinician or pharmacist. Genetic data should always be interpreted within the framework of a comprehensive clinical evaluation.
How common is this variant?
The rs9888739 variant is considered common, with the A and G alleles appearing at varying frequencies across different global ancestral populations.
Frequently asked questions
Is rs9888739 a cause of epilepsy?
No, rs9888739 is a common genetic variant and is not considered a direct cause of epilepsy. While the GABRG2 gene is associated with epilepsy, common SNPs like this one generally have a very small or negligible effect on individual risk.
Should I get tested for GABRG2 variants?
Genetic testing for GABRG2 is typically reserved for clinical settings where a patient has a suspected genetic epilepsy syndrome. You should discuss the necessity of any genetic testing with a neurologist or a genetic counselor.
Can I change my diet to help my GABRG2 variant?
There is no scientific evidence that specific diets can alter the function of the GABRG2 gene or mitigate the effects of common variants like rs9888739. Always consult a doctor before making significant changes to your diet or health regimen.
Where can I find more information on GABRG2?
You can find reliable information on the GABRG2 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide detailed summaries of gene function and known clinical associations.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9888739?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.